Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study

Young-Suk Lim; Chun-Yen Lin; Jeong Heo; Ho Bae; Wan-Long Chuang; Tak Yin Owen Tsang; Claire Fournier; Aric Josun Hui; Trinh Huy; Susanna Tan; Yang Zhao; John F. Flaherty; Vithika Suri; Anuj Gaggar; Diana Brainard; Stephen Ryder; Harry L. A. Janssen

Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study

Young-Suk Lim
, Chun-Yen Lin
, Jeong Heo
, Ho Bae
, Wan-Long Chuang
, Tak Yin Owen Tsang
, Claire Fournier
, Aric Josun Hui
, Trinh Huy
, Susanna Tan
, Yang Zhao
, John F. Flaherty
, Vithika Suri
, Anuj Gaggar
, Diana Brainard
, Stephen Ryder
, Harry L. A. Janssen

School of Medicine

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Journal of Hepatology
Volume	75
State	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Lim, Y.-S., Lin, C.-Y., Heo, J., Bae, H., Chuang, W.-L., Tsang, T. Y. O., Fournier, C., Hui, A. J., Huy, T., Tan, S., Zhao, Y., Flaherty, J. F., Suri, V., Gaggar, A., Brainard, D., Ryder, S., & Janssen, H. L. A. (2021). Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study. Journal of Hepatology, 75.

@article{06f1738bfbd6427687beac1d2036ee92,

title = "Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study",

author = "Young-Suk Lim and Chun-Yen Lin and Jeong Heo and Ho Bae and Wan-Long Chuang and Tsang, \{Tak Yin Owen\} and Claire Fournier and Hui, \{Aric Josun\} and Trinh Huy and Susanna Tan and Yang Zhao and Flaherty, \{John F.\} and Vithika Suri and Anuj Gaggar and Diana Brainard and Stephen Ryder and Janssen, \{Harry L. A.\}",

year = "2021",

language = "American English",

volume = "75",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

}

Lim, Y-S, Lin, C-Y, Heo, J, Bae, H, Chuang, W-L, Tsang, TYO, Fournier, C, Hui, AJ, Huy, T, Tan, S, Zhao, Y, Flaherty, JF, Suri, V, Gaggar, A, Brainard, D, Ryder, S & Janssen, HLA 2021, 'Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study', Journal of Hepatology, vol. 75.

Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study. / Lim, Young-Suk; Lin, Chun-Yen; Heo, Jeong et al.
In: Journal of Hepatology, Vol. 75, 2021.

Research output: Contribution to journal › Journal Article › peer-review

TY - JOUR

T1 - Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study

AU - Lim, Young-Suk

AU - Lin, Chun-Yen

AU - Heo, Jeong

AU - Bae, Ho

AU - Chuang, Wan-Long

AU - Tsang, Tak Yin Owen

AU - Fournier, Claire

AU - Hui, Aric Josun

AU - Huy, Trinh

AU - Tan, Susanna

AU - Zhao, Yang

AU - Flaherty, John F.

AU - Suri, Vithika

AU - Gaggar, Anuj

AU - Brainard, Diana

AU - Ryder, Stephen

AU - Janssen, Harry L. A.

PY - 2021

Y1 - 2021

M3 - Journal Article

SN - 0168-8278

VL - 75

JO - Journal of Hepatology

JF - Journal of Hepatology

ER -